A Study to Evaluate the Rate of Nausea in Healthy Premenopausal Female Subjects Treated With a Single Dose of Bremelanotide Alone or With Zofran

A Study to Evaluate the Rate of Nausea in Healthy Premenopausal Female Subjects Treated With a Single Dose of Bremelanotide Alone or With Zofran

Condition:   Nausea
Interventions:   Drug: Bremelanotide;   Drug: Zofran;   Drug: Placebo
Sponsor:   AMAG Pharmaceuticals, Inc.
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 8, 2019Comments OffAlone | Bremelanotide | Dose | Evaluate | Female | Healthy | Nausea | Premenopausal | Rate | Single | Study | Subjects | Treated | Zofran
Comments